Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03032640 · ClinicalTrials.gov registry record · NA
Interactions of Human Gut Microbiota With Intestinal Sweet Taste Receptors
A NA study, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT03032640 is a NA study that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 102 participants.
The verdict
NCT03032640, a NA study, has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data to examine whether short-term consumption of non-caloric artificial sweeteners (NCASs), such as saccharin, can lead to changes in blood sugar levels and in the composition of the bacteria in the large intestine.
Interventions
- OTHER Placebo
- OTHER Oral Glucose Tolerance Test (OGTT)
- OTHER Assessment of dietary compliance
- OTHER Stool sampling
- OTHER Sodium Saccharin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-01-26 |
| Est. Completion | 2022-10-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03032640
The ClinicalTrials.gov registry entry for NCT03032640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT03032640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03032640 about?
NCT03032640 is a clinical study titled "Interactions of Human Gut Microbiota With Intestinal Sweet Taste Receptors". The purpose of this study is to collect data to examine whether short-term consumption of non-caloric artificial sweeteners (NCASs), such as saccharin, can lead to changes in blood sugar levels and in the composition of the bacteria in the large intestine.
What is the current status of trial NCT03032640?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2017-01-26. Estimated completion is 2022-10-18.
What interventions are being tested in trial NCT03032640?
The interventions under investigation include: Placebo (OTHER), Oral Glucose Tolerance Test (OGTT) (OTHER), Assessment of dietary compliance (OTHER), Stool sampling (OTHER), Sodium Saccharin (OTHER).
Who is sponsoring clinical trial NCT03032640?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.